Skip Navigation


Cardiovascular Research Advance Access originally published online on April 5, 2008
Cardiovascular Research 2008 78(3):411-412; doi:10.1093/cvr/cvn092
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
78/3/411    most recent
cvn092v2
cvn092v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Cardiovasc Res
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dobrev, D.
Right arrow Articles by Wettwer, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dobrev, D.
Right arrow Articles by Wettwer, E.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Four and a half LIM protein 1: a novel chaperone for atrium-specific Kv1.5 channels with a potential role in atrial arrhythmogenesis

Dobromir Dobrev* and Erich Wettwer

Department of Pharmacology and Toxicology, Dresden University of Technology, Fetscher Str 74, 01307 Dresden, Germany

* Corresponding author. Tel: +49 351 458 6279; fax: +49 351 458 6315. E-mail address: dobrev@rcs.urz.tu-dresden.de

This editorial is linked to the article ‘Four and a half LIM protein 1: a partner of KCNA5 in human atrium’ by Z. Yang et al.,7 pp. 449–457, this issue.

The first 10% of the full text of this article appears below.

Chronic atrial diseases are associated with electrical, mechanical, and structural changes (remodelling) that result from activation of diverse signal transduction pathways. In atrial fibrillation (AF), the high atrial rate abbreviates the atrial action potential duration primarily by reduced ICa,L and increased inward-rectifier K+ currents like the background current (IK1) and a constitutively active form of the acetylcholine-dependent K+ current (IK,ACh).1,2 There is also evidence for AF-associated reduction in the ultra-rapid delayed-rectifier IKur, although the reported findings have been inconsistent and the underlying molecular mechanisms are less clear.1 Response rate to antiarrhythmic . . . [Full Text of this Article]


    Funding
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Cardiovasc Res:

Four and a half LIM protein 1: a partner for KCNA5 in human atrium
Zhenjiang Yang, Carrie F. Browning, Haifa Hallaq, Liudmila Yermalitskaya, Jan Esker, Matthew R. Hall, Andrew J. Link, Amy-Joan L. Ham, Meagan J. McGrath, Christina A. Mitchell, and Katherine T. Murray
Cardiovasc Res 2008 78: 449-457. [Abstract] [FREE Full Text]  

Related Article

Four and a half LIM protein 1: a partner for KCNA5 in human atrium
Zhenjiang Yang, Carrie F. Browning, Haifa Hallaq, Liudmila Yermalitskaya, Jan Esker, Matthew R. Hall, Andrew J. Link, Amy-Joan L. Ham, Meagan J. McGrath, Christina A. Mitchell, and Katherine T. Murray
Cardiovasc Res 2008 78: 449-457. [Abstract] [Full Text] [PDF]